Real-world data show maternal RSVpreF vaccination was 82% effective against infant RSV LRTI hospitalization through 3 months.
|Articles|January 12, 2015
OB/GYN Stat Bite: Fetal and perinatal mortality
A new CDC report shows that while perinatal mortality rates are continuing to decline-down 10% since 2000-the US fetal mortality rate for the latest study period (2006–2012) did not improve.
Advertisement
Advertisement
Related to this article
Peter Hsin, BS, discusses a meta-analysis linking perioperative ketamine to lower early postpartum depressive symptoms after cesarean delivery.
The FDA granted accelerated approval to Voceryq to reduce papilloma excision surgeries in adults with recurrent respiratory papillomatosis.
Neither maternal MOUD dose nor umbilical cord opioid levels were associated with neonatal opioid withdrawal syndrome severity.
ACOG advises against GLP-1 receptor agonists in pregnancy and recommends considering discontinuation 1 to 2 months before conception.
This FAQ summarizes a Special Report discussion on how two experts decide who is a candidate for testosterone therapy in women, from symptoms and context to hormone state vs age.
This FAQ summarizes a Special Report discussion of what the evidence does and does not establish about testosterone therapy in women.
Kanchi Chadha, MD, FACOG, MSCP, supports reconsidering MHT boxed warnings but says the FDA cited no study behind the change.
Advertisement
Advertisement
Trending on Contemporary OB/GYN
1
Top video interviews from The Menopause Society 2026 Annual Meeting
2
Q&A: Peter Hsin, BS, on perioperative ketamine and early postpartum depression
3
Centers for Medicare, Medicaid Services includes AMA's obstetric codes in 2027 fee schedule
4
FAQ: Who is a candidate for testosterone therapy in women?
5